Extended survival in a patient with recurrent and metastatic adrenal cortical carcinoma by aggressive transarterial embolization - A case report

Journal of Surgical Oncology

Volumn 90, Issue 2, 2005, Pages 101-105

  Li, Shau Hsuan ^a   Huang, Cheng Hua ^a   Ko, Sheung Fat ^a   Chou, Fong Fu ^a   Huang, Shun Chen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Adrenal cortical carcinoma; Metastatic; Recurrent; Transarterial embolization

Indexed keywords

ALCOHOL; GELFOAM; IODINATED POPPYSEED OIL; LIDOCAINE;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; SAFETY; SPLEEN CANCER; SURVIVAL TIME; SYMPTOM; TREATMENT OUTCOME;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; EMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SPLENIC NEOPLASMS; SURVIVORS;

EID: 17844381553     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20247     Document Type: Article

References (25)

1. Lipsett MB, Hertz R, Ross GT: Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am J Med 1963;35:374-383.
2. Hutter AM, Kayhoe DE: Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 1966;41:572-580.
3. Wooten MD, King DK: Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993;72:3145-3155.
4. Grondal S, Codermark B, Eriksson B, et al.: Adrenocortical carcinoma: A retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 1990;16:500-506.
5. Dackiw APB, Lee JE, Cagel RF, et al.: Adrenal cortical carcinoma. World J Surg 2001;25:914-926.
6. Favia G, Lumachi F, D'Amico D: Adrenocortical carcinoma: Is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 2001;25:735-738.
7. MacFarlane DA. Cancer of the adrenal cortex: The natural history, prognosis, and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958;23:155-186.
8. Henley DJ, van Heerden JA, Grant CS, et al.: Adrenal cortical carcinoma: A continuing challenge. Surgery 1983;94:926-931.
9. Soreide JA, Brabrand K, Thoresen S: Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 1992;16:663-667.
10. Haak HR, Hermans J, van de Velde CJ, et al.: Optimal treatment of adrenal cortical carcinoma with mitotane: Results in a consecutive series of 96 patients. Br J Cancer 1994;69:947-951.
11. Zografos GC, Driscoll D, Karalousis C, et al.: Staging and grading in the survival of adrenal carcinoma. Eur J Surg Oncol 1994;20: 449-453.
12. Crucitti F, Bellantone R, Ferrante A, et al.: The ACC Italian Registry Study Group. The Italian registry for adrenal cortical carcinoma: Analysis of a multiinstitutional series of 129 patients. Surgery 1996;119:161-170.
13. Harrison LE, Gaudin PB, Brennan MF: Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 1999;134:181-185.
14. Schulick R, Brennan M: Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999;6:719-726.
15. Icard P, Goudet P, Charpenay C, et al.: Adrenocortical carcinomas: surgical trends and results of 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg 2001;25:891-897.
16. Pommier R, Brennan MF: An eleven-year experience with adrenocortical carcinoma. Surgery 1992;112:963-971.
17. Bellantone R, Ferrante A, Boscherini M, et al.: Role of reoperation in recurrence of adrenal cortical carcinoma: Results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 1997;122:1212-1218.
18. Venkatesh S, Hickey RC, Sellin RV, et al.: Adrenal cortical carcinoma. Cancer 1989;64:765-769.
19. Luton JP, Cerdas S, Billaud L, et al.: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-1201.
20. Pommier RF, Brennan MF. Management of adrenal neoplasms. Curr Probl Surg 1991;28:657-739.
21. Orlando R, Felizzo MR, Lirussi F: Adrenocortical carcinoma: a 15-year survival after complete resection and repeated resection. A retrospective study in a patient with an expected poor prognosis. Anticancer Res 2003;23:2929-2932.
22. Meyer A, Behrend M: Long-term survival over 28 years of a patient with metastatic adrenal cortical carcinoma-case report. Anticancer Res 2004;24:1901-1904.
23. O'Keeffe FN, Carrasco CH, Charnsangavej C, et al.: Arterial embolization of adrenal tumors: Results in nine cases. Am J Roentgenol 1988;151:819-822.
24. Koh MS, Lee MS, Hong SW, et al.: Partial remission with transarterial embolization in a case of metastatic adrenal cortical carcinoma. J Korean Med Sci 1991;6:173-176.
25. Wood BJ, Abraham J, Hvizda JL, et al.: Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 2003;97:554-560.